Nikolaj Frost MD
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Pemetrexed-free vs. Pemetrexed-based Immunochemotherapy in Metastatic TTF-1 Negative Lung Adenocarcinoma (NCT05689671) | Nikolaj Frost MD | 2023-12-06 |
Track Nikolaj Frost MD automatically
Every clearance here is in the API, with alerts when new ones post.